Ischemic Stroke. Cerebral infarction
Conditions
Interventions
Intervention 1: Intervention group: During the 5 days of hospitalization in the neurology ward, patients in the citalopram intervention group will receive one tablet of citalopram 10 mg once daily dur
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: ?All patients diagnosed with ischemic stroke who admitted to the Neurology Departments .
Exclusion criteria
Exclusion criteria: First-ever ischemic stroke Age between 20 and 80 years NIHSS score < 12 DASS-21 scores: Depression = 6, Anxiety = 5, Stress = 9 Ability to read and write No history of central nervous system disorders such as dementia, Parkinson’s disease, or pre-stroke seizures No history of psychiatric disorders Absence of a history of drug or alcohol abuse or dependence Accessibility throughout the study period No chronic diseases such as cancer or chronic kidney failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression score in the Depression, Anxiety, and Stress Scale questionnaire. Timepoint: Depression scores were measured at baseline and 33 days after the start of the study. Method of measurement: Depression subscale in the Depression, Anxiety, and Stress Scale questionnaire.;Anxiety score in the Depression, Anxiety, and Stress Scale questionnaire. Timepoint: Anxiety scores were measured at baseline and 33 days after the start of the study. Method of measurement: Anxiety subscale in the Depression, Anxiety, and Stress Scale questionnaire.;Stress score in the Depression, Anxiety, and Stress Scale questionnaire. Timepoint: Stress scores were measured at baseline and 33 days after the start of the study. Method of measurement: Stress subscale in the Depression, Anxiety, and Stress Scale questionnaire.;Health anxiety score in the Short Health Anxiety Inventory questionnaire. Timepoint: Health anxiety scores were measured at baseline and 33 days after the start of the study. Method of measurement: Short Health Anxiety Inventory questionnaire.;Obsessive–Compulsive score in the Yale–Brown Obsessive–Compulsive Scale questionnaire. Timepoint: Obsessive–Compulsive scores were measured at baseline and 33 days after the start of the study. Method of measurement: Yale–Brown Obsessive–Compulsive Scale questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Rezvaniamin
Zahedan University of Medical Sciences
Outcome results
None listed